The Use of MR-Guided Radiation Therapy for Pancreatic Cancer

IF 2.6 3区医学 Q3 ONCOLOGY

Seminars in Radiation Oncology Pub Date : 2023-12-15 DOI:10.1016/j.semradonc.2023.10.002

Lois A. Daamen , Parag J. Parikh , William A. Hall

引用次数: 0

Abstract

The introduction of online adaptive magnetic resonance (MR)-guided radiation therapy (RT) has enabled safe treatment of pancreatic cancer with ablative doses. The aim of this review is to provide a comprehensive overview of the current literature on the use and clinical outcomes of MR-guided RT for treatment of pancreatic cancer. Relevant outcomes included toxicity, tumor response, survival and quality of life. The results of these studies support further investigation of the effectiveness of ablative MR-guided SBRT as a low-toxic, minimally-invasive therapy for localized pancreatic cancer in prospective clinical trials.

查看原文本刊更多论文

使用磁共振引导放射治疗胰腺癌

在线自适应磁共振（MR）引导放射治疗（RT）的引入，使胰腺癌的安全消融治疗成为可能。本综述旨在全面概述目前有关磁共振引导 RT 治疗胰腺癌的应用和临床结果的文献。相关结果包括毒性、肿瘤反应、生存率和生活质量。这些研究结果支持在前瞻性临床试验中进一步研究 MR 引导的 SBRT 作为低毒、微创疗法治疗局部胰腺癌的有效性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Seminars in Radiation Oncology 医学-核医学

CiteScore

5.80

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Each issue of Seminars in Radiation Oncology is compiled by a guest editor to address a specific topic in the specialty, presenting definitive information on areas of rapid change and development. A significant number of articles report new scientific information. Topics covered include tumor biology, diagnosis, medical and surgical management of the patient, and new technologies.